21.16 USD
↘ 0.22 (1.01%)LIVE (AS OF 12:21 PM EST)
Tyra Biosciences, Inc. Common Stock
TYRANASDAQ • USD
Market: OPEN
Tyra Biosciences, Inc. Common Stock (TYRA) is currently trading at $21.16. Our models show a "Neutral" technical signal alongside a "Sell" fundamental rating. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place TYRA at a fair price relative to peers.
Technical & fundamental data as of Nov 3, 2026.
Open?$21.91
High?$22.27
Low?$19.98
Prev. Close?$21.37
Volume?253.3K
Avg. Volume?703.9K
VWAP?$21.23
Rel. Volume?0.36x
Bid / Ask
Bid?$18.09 × 200
Ask?$21.16 × 300
Spread?$3.07
Midpoint?$19.63
Valuation & Ratios
Market Cap?1.5B
Shares Out?59.7M
Float?35.9M
Float %?60.1%
P/E Ratio?N/A
P/B Ratio?4.15
EPS?-$2.16
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
Themes
Address
2656 STATE STREET
CARLSBAD, CA 92008
Phone: (619) 728-4760
CARLSBAD, CA 92008
Phone: (619) 728-4760
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?23
Short Sent.?10
Piotroski F-Score?0/9Weak
Altman Z-Score?27.71Safe
Confidence?48%Low
Short InterestSqueeze Risk
Short % of Float?26.46%Squeeze Risk
Short Interest?9.5M
Days to Cover?15.3
Free Float35.9M
Avg Daily Volume619.6K
Settlement Date2026-10-15
Financial Health
Current Ratio?14.91Strong
Quick Ratio?14.91Strong
Cash Ratio?3.00Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?4.15FAIR▾
Peers100
S&P43
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-8.7CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-41.9%WEAK▾
S&P3
ROA?-38.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-109901000
Enterprise Value?$1.4B
Fundamentals ratios updated end of day